Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

Published: May 1, 2003 | Price: $2,625.00 – $5,250.00

Genetic testing is already in widespread use and will continue to grow in many application areas in the next five years. The number of companies offering genetic testing services and/or commercial genetic testing products continues to grow around the world. There are at least 50 companies offering genetic testing services or commercial products for a genetic test in medical, GMO food safety, forensics, and paternity applications. In the area of medical genetics, tests and services can vary by disease. Under...

Outsourcing in Drug Discovery

Published: May 1, 2003 | Price: $2,062.00 – $4,152.00

The number and scope of drug discovery outsourcing agreements has grown rapidly over the past five years, and the pace will accelerate over the next five years. Outsourcing is now an essential part of drug discovery. Major pharmas and biotechs are aggressively pursuing a range of outsourcing agreements. On the supplier side, smaller vendors rely on outsourcing revenues to pay their bills and boost their credibility. Outsourcing in drug discovery is a popular topic for trade articles and seminars. These...

Diabetes in Germany: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications

Published: April 1, 2003 | Price: $371.00 – $742.00

The market for diabetes care products covers the spectrum of clinical medicine, including diagnostics, biologics, and drugs. Several areas have strong growth potential and others, such as drugs to treat complications, represent large underserved markets for drugs primarily marketed to other populations. Segmentation of patient populations in novel ways, such as diabetic candidates for cardiovascular drugs, presents an excellent opportunity to expand markets and influence prescription practices in some markets. Scope and Methodology In addition to epidemiology of diabetes Type...

World Market for Anti-infectives Series: Volumes I – III – Antifungals, Antibacterials and Antivirals, The

Published: April 1, 2003 | Price: $6,000.00 – $12,000.00

Once a public health problem pegged for easy elimination, infectious diseases continue to be the leading cause of death worldwide. Despite improved methods of treating and preventing infection, including potent antibiotics, comprehensive immunization, and modern sanitation, infection still accounts for much serious illness, even in highly industrialized countries. Use this new Kalorama Information 3-volume series to evaluate your organization's position in the highly active anti-infectives market. Volume I Abstract The World Market for Antifungal Medications The market for pharmaceuticals targeted...

Diabetes in France: The Markets for Monitoring, Insulin, Oral Hypoglycemics, and Drugs to Treat Complications

Published: March 1, 2003 | Price: $371.00 – $742.00

Diabetes monitoring and therapeutics to manage the disease and its complications continues to be an attractive market for many manufacturers. However, the factors that affect the potential of diabetes markets—including population demographics and the attitude of healthcare policy makers and clinicians—can seem like shifting sands from one country to the next. That’s why Kalorama is now offering affordable country-specific profiles on the diabetes markets that provide you with the facts you need to implement your strategy in each of the...

U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays

Published: March 1, 2003 | Price: $250.00 – $5,250.00

The world of analytical microchips is the fastest growing technology segment in the life sciences today. The range of applications to which these miniature laboratories may be directed is very broad--covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, the number of applications is rapidly expanding through the development of significant enabling technologies. Where chips were initially envisioned as carriers of microscopic binding sites...

Neurologic Cancers: Selections from “The World Market for Neurotherapeutic Drugs”

Published: January 1, 2003 | Price: $1,121.00 – $1,717.00

In the summer of 2002, Kalorama Information released a major study on non-psychiatric neurotherapeutic drug markets. At almost 500 pages, the resulting report covered a broad range of neurological agents comprehensively and in depth; however, the breadth and authority of the results proved to be more information than some marketers needed. Smaller biopharmaceutical concerns—some of the real drivers of this market—are more focused on individual neurological disorders such as multiple sclerosis, Alzheimer’s disease, or neurological cancers, rather than the broad...

Drug Delivery Markets: Oral Delivery

Published: July 1, 2000 | Price: $995.00 – $5,990.00

Since our last edition of this report in 2007, the oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the growing elderly population that requires products with a level of ease-of-use and cost benefit, it’s no surprise that the oral drug delivery market is a...